Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-15-Speech-2-593-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110215.29.2-593-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"The pharmaceutical industry is one of the three most lucrative industries. It is certainly one of the main reasons why counterfeit pharmaceuticals are spreading on to the market. Last year, customs confiscated 384% more counterfeit pharmaceuticals than were confiscated five years ago. In combating this phenomenon, it is very important to accept unified security measures within the European Union, including repackaging. Patients need to have complete confidence that any medication they are taking is indeed what they think it is and that the active ingredient in the prescription corresponds to what is in the medication. From the perspective of national health, it is of the utmost importance that the medication should be effective, high quality and safe. False information campaigns by third-party pharmaceutical companies that have procured a licence to sell from competent institutions must be prohibited. This prohibition should also be extended to information and advertising distributed to medical staff."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples